Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.45 is 109% above its 2-year average of 0.21, near the high end of its 2-year range (0.02–0.62).
As of the fiscal period ended Wednesday, December 31, 2025. 16.51% above its 12-month average of 0.38.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.45.
QUICK RATIO (ACID-TEST)
0.45
QUICK RATIO (ACID-TEST) AVG TTM
0.38
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.51%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 733 covered companies
CURRENT VS SECTOR MEDIAN
-86.00%
vs the sector median at left
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$155.86M
Quick Ratio (Acid-Test)
0.45
TTM Avg
0.38
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.40M
Quick Ratio (Acid-Test)
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$151.58M
Quick Ratio (Acid-Test)
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.44
Market Cap
$158.63M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$149.66M
Quick Ratio (Acid-Test)
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$151.12M
Quick Ratio (Acid-Test)
2.99
TTM Avg
3.92
3Y Avg
3.42
5Y Avg
4.30
Market Cap
$162.20M
Quick Ratio (Acid-Test)
13.36
TTM Avg
9.68
3Y Avg
8.92
5Y Avg
10.26
Market Cap
$149.51M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $155.86M | 0.45 | 0.38 | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | 9.71 | 4.67 | 6.04 | 19.74 |
| Inogen, Inc. (INGN)vs › | $158.12M | 2.34 | 2.40 | 2.87 | 3.55 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | 5.55 | 4.34 | 4.83 | 5.44 |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | 20.14 | 22.07 | 21.46 | 19.43 |
| Anavex Life Sciences Corp. (AVXL)vs › | $149.66M | 15.62 | 10.23 | 11.93 | 11.24 |
| Codexis, Inc. (CDXS)vs › | $151.12M | 2.99 | 3.92 | 3.42 | 4.30 |
| PepGen Inc. (PEPG)vs › | $162.20M | 13.36 | 9.68 | 8.92 | 10.26 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.51M | 2.47 | 5.26 | 13.15 | 16.36 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | 1.23 | 1.14 | 1.35 | 4.96 |
Quick Ratio
0.45
Excludes inventory
Current Ratio
0.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 0.45 |
| 2025-09-30 | 0.45 |
| 2025-06-30 | 0.62 |
| 2024-12-31 | 0.02 |
| 2024-09-30 | 0.02 |
| 2024-06-30 | 0.02 |
| 2024-03-31 | 0.02 |
| 2023-12-31 | 0.13 |
